Company Profile: Becton, Dickinson and Company (BDX)

BDX insider trades (13 months) →

$198.17 −0.22% vs. previous close · Market cap $53.98B

Today's multi-factor rank: 240 of 461 · see the ranking

Quant500 Scores

Momentum

6.3/10

Value

4.8/10

Growth

3.9/10

Quality

4.4/10

Multifactor

4.9/10

Market and Valuation

Price & Market

Prev Close Price:$198.60

Open:$197.16

Day's Low:$196.24

Day's High:$199.17

Bid / Ask:-

Market Cap:53.98B

Enterprise Value:70.20B

52-Week Range

52-Week Low:$127.59

52-Week High:$200.47

Current position in 52-week range

52w Low-52w High

50-Day Avg:$186.73

200-Day Avg:$166.15

Volume

Volume Today:1,956,404

Avg Volume (3m):1,742,635

Avg Volume (10d):1,628,090

52-Week Change:+41.10%

vs S&P 500, 52 weeks:-

Beta:0.28

Valuation Multiples

P/E (trailing):59.69

Diluted EPS for the last 12 months: the four quarters ended Jun 30, 2026, from the accounts filed with the SEC on Aug 6, 2026. The P/E is the price divided by that EPS.

P/E (forward):14.90

PEG Ratio:1.11

Price / Book:2.21

Price / Sales (TTM):2.40

EV / Revenue:3.12

EV / EBITDA:11.47

Dividends

Current yield:2.11%

Annual Dividend Rate:$4.20

Dividend Trailing:$4.19

Yield Trailing:2.11%

5-Year Avg Yield:1.66%

Payout Ratio:72.49%

Last Ex-Dividend Date:-

Valuation Context

P/E vs sector (indicative)

Most Recent Quarter:-

Fiscal Year (Next):-

Date Filter (Month):

Loading historical OHLCV database...

Financial Statements TTM (Trailing 12 Months)

Income Statement

Total Revenue (TTM):22.48B

Gross Profit:10.55B

EBITDA:6.12B

Net Income (TTM):1.65B

Rev Growth (YoY):+5.40%

Earnings Growth (YoY):-31.40%

Quarterly earnings growth (YoY):-34.30%

Margins

Gross Margin:-

EBITDA Margin:-

Operating Margin:-

Net Margin:-

Per Share

EPS Trailing (TTM):$3.32

Diluted EPS for the last 12 months: the four quarters ended Jun 30, 2026, from the accounts filed with the SEC on Aug 6, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$13.30

Revenue Per Share:$79.76

Cash Per Share:-

Book Value:$89.64

Last Dividend:-

Ex-Dividend Date:-

Last Split:-

Balance Sheet & Liquidity

Total cash:709.00M

Total Debt:16.81B

Net Debt (Debt - Cash):16.10B

Debt / Equity:68.84%

Current Ratio:0.87

Quick Ratio:0.33

Cash Flows

Operating Cash Flow:3.34B

Free Cash Flow (FCF):4.48B

FCF Yield (FCF / Market Cap):-

Enterprise Value:70.20B

EV / Revenue:3.12

EV / EBITDA:11.47

Profitability

ROE (Return on Equity):6.61%

ROA (Return on Assets):4.34%

P/E (trailing):59.69

P/E (forward):14.90

Price / Book:2.21

PEG Ratio:1.11

52-Week Change:+41.10%

S&P 500 change, 52 weeks:+11.37%

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

EPS Trailing (TTM):$3.32

Diluted EPS for the last 12 months: the four quarters ended Jun 30, 2026, from the accounts filed with the SEC on Aug 6, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$13.30

P/E (forward):14.90

PEG Ratio:1.11

Growth and Margins

Earnings Growth YoY:-

Quarterly Earnings Growth YoY:-

Rev Growth YoY:-

Net Margin:-

Gross Margin:-

EBITDA Margin:-

Per Share

Revenue Per Share:$79.76

Cash Per Share:-

Book Value:$89.64

Cash Flows (TTM)

Free Cash Flow:4.48B

Operating Cash Flow:3.34B

EBITDA:6.12B

Total Revenue (TTM):22.48B

Net Income (TTM):1.65B

Fiscal Year (Last):-

EPS Surprise History - Last 4 Quarters

Actual vs. Analyst Estimates · Green = beat expectations · Red = missed

Quarter	Period	Actual EPS	Estimated EPS	Difference	Surprise %	Currency

Ownership Structure

Ownership Distribution

% Insiders:-

% Institutional:-

% Inst. (of Float):-

No. of Institutions:-

Visual distribution

InsidersInstitutionalFree Float

Shares & Short Interest

Shares Outstanding:272,386,800

Float (free shares):271,664,975

Short interest (shares):8,907,876

Short % of float:-

Short Ratio (days to cover):4.88

Short interest, prior month:-

Short Interest Date:-

Governance Score (1=Best, 10=Worst)

Overall risk:-

Audit Risk:-

Board risk:-

Compensation Risk:-

Shareholder rights risk:-

Top Institutional Holders

Position Change: ▲ Increased · ▼ Reduced · = Unchanged

Organization	Report Date	% Shares	No. Shares	Value (USD)	Change %

Top Mutual Funds

Position Change: ▲ Increased ▼ Decreased = Unchanged

Fund	Report Date	% Shares	No. Shares	Value (USD)	Change %

Recent Insider Trades

Executive / Insider	Title	Date	Action	Shares

Options Chain

Expiration Date:

CALLS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

PUTS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

Becton, Dickinson and Company (BDX) SEC filings: 10-K, 10-Q and 8-K

Direct links to financial reports filed with the SEC.

Type	Date	Official link
8-K	2026-08-06	View filing ↗
8-K	2026-07-22	View filing ↗
11-K	2026-06-29	View filing ↗
8-K	2026-05-29	View filing ↗
SD	2026-05-22	View filing ↗
8-K	2026-05-20	View filing ↗
8-K	2026-05-12	View filing ↗
S-8	2026-05-07	View filing ↗
8-K	2026-04-29	View filing ↗
8-K	2026-04-09	View filing ↗

Company and Executive Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

General Information

Headquarters:United States

City:Franklin Lakes

Employees:72,000

Sector:Healthcare

Industry:Medical Instruments & Supplies

Website:-

Key Executives

Name	Title	Age	Total pay
Mr. Thomas E. Polen Jr.	President, CEO & Chairman	52	3.59M
Mr. Michael C. Feld	Executive VP & Chief Revenue Officer	44	1.91M
Mr. Vitor Roque	Executive VP & CFO	42	-
Ms. Elizabeth McCombs	Executive VP & CTO	48	-
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.	Senior VP & Chief Scientific Officer	-	-
Mr. Arthur Hu	Executive VP and Chief Information & Digital Officer	-	-
Mr. Shawn C. Bevec	Senior Vice President of Investor Relations	-	-
Ms. Lanesha T. Minnix J.D.	Executive VP & General Counsel	50	-

You have seen the engine room

A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.

No card. No spam.

Becton, Dickinson and Company (BDX): Quantitative Analysis

Name: Factor scores for Becton, Dickinson and Company (BDX)
Creator: Quant500
License: https://quant500.com/legal

Becton, Dickinson and Company (BDX) — Healthcare — Medical Instruments & Supplies. BDX is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.

So far in 2026, BDX has returned +32.0% against +11.4% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Nov 3, 2026.

BDX ranks 240 of 461 on today's multifactor score, and 33 of the 55 Healthcare companies that score. Its strongest factor is momentum (Z 0.80, ranked 87 of 494); its weakest is growth (Z -0.65, ranked 450 of 489). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.

Factor scores

The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.

Factor	Z-Score	Rank
Multifactor	-0.080	240 of 461
Momentum	0.800	87 of 494 ↑12
Value	-0.131	239 of 489
Quality	-0.340	337 of 468
Growth	-0.649	450 of 489

Market data

Metric	Value
Price	$198.17
Market Cap	53.98B
P/E	59.69
Revenue (last 12 months)	22.48B
Price / book	2.21
Book value per share	$89.64
52-week range	$127.59 – $200.47
Dividend yield	2.11%
Beta	0.28
Average volume	1,742,635
Shares outstanding	272.39M
Short interest (% of float)	3.73% (as of Oct 15, 2026)

When does BDX report earnings? 11 of its last 12, before the open →

What are BDX insiders doing? 77 transactions filed with the SEC, of them 25 sells, the last one on Oct 26, 2026 →

BDX latest SEC filings

Annual report (10-K): filed Nov 25, 2025, fiscal year ended Sep 30, 2025 · see its 10-K filings on sec.gov
Quarterly report (10-Q): filed Aug 6, 2026, quarter ended Jun 30, 2026 · see its 10-Q filings on sec.gov
Earnings release (8-K): Aug 6, 2026, before the open · view the 8-K on sec.gov

Filing dates on EDGAR, the SEC's public registry. All BDX filings on EDGAR.

Guides: How to read a Quant500 company page · What the S&P 500 is · P/E ratio explained · 10-K, 10-Q and 8-K · all guides

Frequently asked questions about Becton, Dickinson (BDX)

When does Becton, Dickinson report earnings?

According to Nasdaq's public calendar (checked on Nov 4, 2026), Becton, Dickinson will report its next earnings on Nov 5, 2026, before the US market opens. The date is announced by the company itself and can change. Of its last 12 earnings announcements: 1 after the close and 11 before the open (SEC filings through Aug 6, 2026). BDX earnings dates and times, quarter by quarter →

What is Becton, Dickinson's P/E ratio?

Becton, Dickinson's P/E (price over earnings per share for the last twelve months) is 59.7 at the Nov 3, 2026 close. That EPS is the 12-month diluted figure from the SEC, the four quarters ended Jun 30, 2026. The median of the 54 Healthcare companies with a P/E is 30.5, and the S&P 500's, 23.5: Becton, Dickinson is above its sector median. Healthcare stocks, company by company →

Where does Becton, Dickinson rank on Quant500?

In the Nov 3, 2026 multi-factor ranking, Becton, Dickinson ranks 240 of 461, and 33 of the 55 Healthcare companies that score. The ranking orders S&P 500 companies by the average of four factors (momentum, value, quality and growth) and is recalculated every trading day. It is a model output, not investment advice. The full ranking → How it is calculated →

Have Becton, Dickinson insiders bought or sold shares?

SEC Form 4 shows no open-market purchase of Becton, Dickinson shares from August 2025 through Nov 3, 2026. The latest sale was on Oct 26, 2026, by an officer, for $15k. In total, from August 2025 through Nov 3, 2026: 0 purchases and 25 sales by directors, officers and large shareholders. All BDX insider trades →

Does Becton, Dickinson pay a dividend?

Yes. Its dividend yield is 2.11% at the Nov 3, 2026 close (annual dividend of $4.20 per share). The latest recorded ex-dividend date is Sep 9, 2026.

What sector is Becton, Dickinson in, and which index?

Becton, Dickinson is classified in the Healthcare sector (industry: Medical Instruments & Supplies), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 59 S&P 500 companies in that sector. Healthcare stocks →

What is behind these numbers

The concepts on this page, explained from scratch in the Academy. Free, no account.

Valuation multiples: P/E, P/B, EV/EBITDA and their trapsWhy the P/E and the price-to-book in the table above cannot be compared across sectors, and what a low P/E can hide.
Value and momentum: the two that have survived bestWhat the value and momentum scores on this page actually measure, and why they are the two factors that have best survived scrutiny.
Quality and low volatilityWhere the quality score comes from, and why it is the factor with the most competing definitions, all of them called the same thing.
Sales growth: the driver that gets overestimated mostWhat sits behind the growth score and the twelve-month revenue, and why it is the number people extrapolate too far most often.
Dividends and payout: high is not always goodThis company pays a dividend and its yield is in the table above: when a high figure is good news and when it is a warning.

The whole Academy, course by course →

Data as of Nov 3, 2026. Source: point-in-time SEC fundamentals and closing prices. Method and formulas are on the home page.

Company Profile: Becton, Dickinson and Company (BDX)

Market and Valuation

Price & Market

52-Week Range

Volume

Valuation Multiples

Dividends

Valuation Context

Financial Statements TTM (Trailing 12 Months)

Income Statement

Margins

Per Share

Balance Sheet & Liquidity

Cash Flows

Profitability

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

Growth and Margins

Per Share

Cash Flows (TTM)

EPS Surprise History - Last 4 Quarters

Ownership Structure

Ownership Distribution

Shares & Short Interest

Governance Score (1=Best, 10=Worst)

Top Institutional Holders

Top Mutual Funds

Recent Insider Trades

Options Chain

CALLS

PUTS

Sentiment Metrics

Expected move

Becton, Dickinson and Company (BDX) SEC filings: 10-K, 10-Q and 8-K

Company and Executive Profile

General Information

Key Executives

You have seen the engine room

Becton, Dickinson and Company (BDX): Quantitative Analysis

Factor scores

Market data

BDX latest SEC filings

Frequently asked questions about Becton, Dickinson (BDX)

When does Becton, Dickinson report earnings?

What is Becton, Dickinson's P/E ratio?

Where does Becton, Dickinson rank on Quant500?

Have Becton, Dickinson insiders bought or sold shares?

Does Becton, Dickinson pay a dividend?

What sector is Becton, Dickinson in, and which index?

What is behind these numbers